Europe Life Sciences Weekly Brief – Sovereign Cloud, Biogen’s Apellis Bet, and Europe’s Tightening Execution Layer
Week of 30 March–5 April 2026 (#31) This was a week of infrastructure hiding in plain sight. A sovereign-cloud launch, a large rare-disease acquisition, EU funding for generative-AI cancer research, and a cluster of regulatory deadlines all pointed to the same underlying shift: life sciences is moving from digital ambition to execution architecture. Commercial Moves…